Gut microbiota‐dependent trimethylamine N‐oxide and cardiovascular outcomes in patients with prior myocardial infarction: A nested case control study from the PEGASUS‐TIMI 54 trial

Gencer, B., Li, X.S., Gurmu, Y. et al. (10 more authors) (2020) Gut microbiota‐dependent trimethylamine N‐oxide and cardiovascular outcomes in patients with prior myocardial infarction: A nested case control study from the PEGASUS‐TIMI 54 trial. Journal of the American Heart Association, 9 (10). e015331. ISSN 2047-9980

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2020 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, (https://creativecommons.org/licenses/by-nc-nd/4.0/) which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made
Keywords: gut microbiota; myocardial infarction; stroke; cardiovascular death; antiplatelet therapy; ticagrelor; trimethylamine N‐oxide
Dates:
  • Accepted: 10 March 2020
  • Published (online): 5 May 2020
  • Published: 18 May 2020
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 12 Jun 2020 15:47
Last Modified: 12 Jun 2020 15:47
Status: Published
Publisher: Ovid Technologies (Wolters Kluwer Health)
Refereed: Yes
Identification Number: https://doi.org/10.1161/jaha.119.015331
Related URLs:

Download

Share / Export

Statistics